Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Volodymyr G Bdzhola

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Journal of Enzyme Inhibition and Medicinal Chemistry|April 13, 2013
Design, synthesis and evaluation of 2-phenylisothiazolidin-3-one-1,1-dioxides as a new class of human protein kinase CK2 inhibitorsMaksym O Chekanov, Olga V Ostrynska, Anatoliy R Synyugin, et al.
Journal of Computational Chemistry|January 4, 2008
Kirchhoff atomic charges fitted to multipole moments: implementation for a virtual screening systemOlexander Yakovenko, Alexander A Oliferenko, Volodymyr G Bdzhola, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2013
Identification of novel PARP-1 inhibitors by structure-based virtual screeningKevin Hannigan, Shridhar S Kulkarni, Volodymyr G Bdzhola, et al.
Journal of Medicinal Chemistry|October 27, 2006
Evaluation of 3-carboxy-4(1H)-quinolones as inhibitors of human protein kinase CK2Andriy G Golub, Olexander Ya Yakovenko, Volodymyr G Bdzhola, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2014
ASK1 pharmacophore model derived from diverse classes of inhibitorsSergiy A Starosyla, Galyna P Volynets, Volodymyr G Bdzhola, et al.
ACS Chemical Biology|May 12, 2015
A Note of Caution on the Role of Halogen Bonds for Protein Kinase/Inhibitor Recognition Suggested by High- And Low-Salt CK2α Complex StructuresBarbara Guerra, Nils Bischoff, Volodymyr G Bdzhola, et al.
Pharmaceuticals (Basel, Switzerland)|January 14, 2017
Structural Hypervariability of the Two Human Protein Kinase CK2 Catalytic Subunit Paralogs Revealed by Complex Structures with a Flavonol- and a Thieno[2,3-d]pyrimidine-Based InhibitorKarsten Niefind, Nils Bischoff, Andriy G Golub, et al.
Journal of Molecular Modeling|May 13, 2011
Ab initio parameterization of YFF1, a universal force field for drug-design applicationsOlexandr Ya Yakovenko, Yvonne Y Li, Alexander A Oliferenko, et al.
Future Microbiology|July 15, 2020
Novel isoniazid derivative as promising antituberculosis agentGalyna P Volynets, Michail A Tukalo, Volodymyr G Bdzhola, et al.
Bioorganic & Medicinal Chemistry|April 18, 2015
Identification of apoptosis signal-regulating kinase 1 (ASK1) inhibitors among the derivatives of benzothiazol-2-yl-3-hydroxy-5-phenyl-1,5-dihydro-pyrrol-2-oneSergiy A Starosyla, Galyna P Volynets, Sergiy S Lukashov, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Journal of Enzyme Inhibition and Medicinal Chemistry|April 13, 2013
Design, synthesis and evaluation of 2-phenylisothiazolidin-3-one-1,1-dioxides as a new class of human protein kinase CK2 inhibitorsMaksym O Chekanov, Olga V Ostrynska, Anatoliy R Synyugin, et al.
Journal of Computational Chemistry|January 4, 2008
Kirchhoff atomic charges fitted to multipole moments: implementation for a virtual screening systemOlexander Yakovenko, Alexander A Oliferenko, Volodymyr G Bdzhola, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2013
Identification of novel PARP-1 inhibitors by structure-based virtual screeningKevin Hannigan, Shridhar S Kulkarni, Volodymyr G Bdzhola, et al.
Journal of Medicinal Chemistry|October 27, 2006
Evaluation of 3-carboxy-4(1H)-quinolones as inhibitors of human protein kinase CK2Andriy G Golub, Olexander Ya Yakovenko, Volodymyr G Bdzhola, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2014
ASK1 pharmacophore model derived from diverse classes of inhibitorsSergiy A Starosyla, Galyna P Volynets, Volodymyr G Bdzhola, et al.
ACS Chemical Biology|May 12, 2015
A Note of Caution on the Role of Halogen Bonds for Protein Kinase/Inhibitor Recognition Suggested by High- And Low-Salt CK2α Complex StructuresBarbara Guerra, Nils Bischoff, Volodymyr G Bdzhola, et al.
Pharmaceuticals (Basel, Switzerland)|January 14, 2017
Structural Hypervariability of the Two Human Protein Kinase CK2 Catalytic Subunit Paralogs Revealed by Complex Structures with a Flavonol- and a Thieno[2,3-d]pyrimidine-Based InhibitorKarsten Niefind, Nils Bischoff, Andriy G Golub, et al.
Journal of Molecular Modeling|May 13, 2011
Ab initio parameterization of YFF1, a universal force field for drug-design applicationsOlexandr Ya Yakovenko, Yvonne Y Li, Alexander A Oliferenko, et al.
Future Microbiology|July 15, 2020
Novel isoniazid derivative as promising antituberculosis agentGalyna P Volynets, Michail A Tukalo, Volodymyr G Bdzhola, et al.
Bioorganic & Medicinal Chemistry|April 18, 2015
Identification of apoptosis signal-regulating kinase 1 (ASK1) inhibitors among the derivatives of benzothiazol-2-yl-3-hydroxy-5-phenyl-1,5-dihydro-pyrrol-2-oneSergiy A Starosyla, Galyna P Volynets, Sergiy S Lukashov, et al.
Pageof 4